| ID | Sequence | Length | GC content |
|---|---|---|---|
| AGUCUGUCUCCGGCGCCGCCCGUCGCGGACUCGUCCUUGCUGCAGUCGC… | 2381 nt | 0.5855 | |
| AAAGUUCUCAGUUGGCCCGUGUGAGGAGAAGGCCGGGGCAGCGGAGGCU… | 2061 nt | 0.5682 | |
| AGUCUGUCUCCGGCGCCGCCCGUCGCGGACUCGUCCUUGCUGCAGUCGC… | 2256 nt | 0.5860 |
The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is activated by mitogenic and environmental stress, and participates in the MAP kinase-mediated signaling cascade. It phosphorylates and thus activates MAPK14/p38-MAPK. This kinase can be activated by insulin, and is necessary for the expression of glucose transporter. Expression of RAS oncogene is found to result in the accumulation of the active form of this kinase, which thus leads to the constitutive activation of MAPK14, and confers oncogenic transformation of primary cells. The inhibition of this kinase is involved in the pathogenesis of Yersina pseudotuberculosis. Multiple alternatively spliced transcript variants that encode distinct isoforms have been reported for this gene. [provided by RefSeq, Jul 2008]
A study in rats demonstrated that the MAP2K3 was the most upregulated differentially expressed mRNA with the largest fold change in lung tissue following hemorrhagic shock-induced acute lung injury/acute respiratory distress syndrome, identifying it as an essential component of the MAPK signaling pathway [Wang et al. DOI:10.1097/TA.0000000000003119].